Table 5.

Antifungal therapy for people with advanced HIV disease based on fungal opportunistic infections.

Antifungal Therapy	Among Patients with Positive Histoplasmosis Test (n = 12/21)	Among Patients with Positive Cryptococcosis Test (n = 2/8)	No Histoplasmosis or Cryptococcosis Confirmed (n = 8)
Itraconazole	11	0	1
Fluconazole	2	2	8
Amphotericin B	2 *	0	1

Note: Antifungal therapy results are not mutually exclusive. One participant with histoplasmosis received all three drugs, and one received itraconazole and amphotericin. From participants with no FOI, one received all three drugs. * Combined with itraconazole.